Parenteral Nutrition Market-By Composition (Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals), Type (RTU, Compounded), Consumer (Children and Newborns, Adults), End-user (Hospitals, Clinics, Homecare) & Global Forecast 2023-2032

Description

List of Tables

Global Parenteral Nutrition Market will witness 7.1% CAGR between 2023 and 2032, propelled by a surge in product launches by industry leaders. Major companies introducing advanced formulations and delivery systems cater to diverse patient needs. These innovations focus on improved nutrient profiles, enhanced compatibility, and reduced risks, driving market expansion.

For instance, in October 2023, Baxter Korea unveiled Olimel N12E, a protein-rich Total Parenteral Nutrition (TPN) solution tailored for critically ill patients and covered by health insurance. With each 1,000 mL, Olimel N12E packs 76 grams of amino acids and 950 calories, presenting a significant 33 percent boost in amino acids compared to Baxter's prior multivitamin fluid, Olimel N9E. This enhancement maintains dosage while elevating the amino acid content. Available in 1,000 mL, 1,500 mL, 2,000 mL, and a smaller 650 mL size, patients gain flexibility in selecting fluid volumes to match their nutritional needs.

With an emphasis on addressing nutritional deficiencies in critical care, oncology, and premature infant care, the market experiences an upswing due to these cutting-edge offerings, marking a pivotal era in meeting specialized nutritional requirements globally.

The overall Parenteral Nutrition Market share is classified based on the composition, end-user, and region.

Fats segment will undergo significant development from 2023 to 2032. Fats play a pivotal role in providing essential nutrients and calories crucial for patients unable to consume food orally. These lipid-based components offer concentrated energy sources, aiding in the maintenance of healthy body functions. As healthcare providers prioritize tailored nutrition, fats in parenteral nutrition solutions become indispensable for addressing malnutrition, supporting recovery, and meeting the specific dietary needs of patients across diverse medical conditions.

Parenteral nutrition market size from the homecare settings segment will register a noteworthy CAGR from 2023 to 2032. Home-based patients unable to intake food orally benefit from tailored parenteral nutrition solutions. These convenient therapies ensure patients receive vital nutrients intravenously, promoting recovery and sustaining health. As healthcare shifts towards patient-centric homecare, the demand for parenteral nutrition rises, enabling individuals with complex medical needs to receive essential nourishment in the comfort of their homes, enhancing their quality of life and aiding in their recuperation.

Europe parenteral nutrition industry will showcase a commendable CAGR from 2023 to 2032. With an aging population and rising prevalence of chronic conditions, the need for specialized nutritional support amplifies. Parenteral nutrition, addressing critical care, malnutrition, and digestive disorders, becomes vital. Additionally, advancements in formulations and infusion technologies enhance patient outcomes. As European healthcare systems prioritize patient-centric care, the demand for tailored parenteral nutrition solutions rises, reflecting a pivotal era in meeting diverse nutritional needs across the continent.

Product Code: 3216

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast Calculation
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Parenteral nutrition industry 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Composition trends
- 2.1.4 Type trends
- 2.1.5 Consumer trends
- 2.1.6 End-user trends

Chapter 3 Parenteral Nutrition Market Insights

3.1 Industry ecosystem
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Increasing metabolic disorders and other chronic diseases
  - 3.3.1.2 Growing malnutrition across the globe
  - 3.3.1.3 Rising geriatric population
  - 3.3.1.4 Increasing rate of pre-mature birth & birth rate
  - 3.3.1.5 Growing adoption of home healthcare settings in developed countries
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Lack of clinical evidence to support novel technology
  - 3.3.2.2 Lack of awareness in developing countries
3.4 Growth potential analysis
- 3.4.1 By composition
- 3.4.2 By type
- 3.4.3 By consumer
- 3.4.4 By end-user
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 China
- 3.6.3 India
- 3.6.4 Europe
  - 3.6.4.1 Germany
  - 3.6.4.2 UK
  - 3.6.4.3 France
  - 3.6.4.4 Italy
  - 3.6.4.5 Spain
3.7 Innovation outlook
- 3.7.1 Innovation landscape
- 3.7.2 Technology evolution
- 3.7.3 Future innovation outlook of the market
- 3.7.4 Initiatives undertaken/proposed by key companies
3.8 Value chain analysis
3.9 Pricing analysis
- 3.9.1 By region
- 3.9.2 By country
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
- 4.1.1 Fresenius Kabi AG
- 4.1.2 Baxter International, Inc
- 4.1.3 B Braun Melsungen AG
4.2 Company matrix analysis
4.3 Company positioning matrix, 2022
4.4 Company market share analysis, 2022
- 4.4.1 Global
  - 4.4.1.1 Global RTU/Standard commercial parenteral nutrition
  - 4.4.1.2 Global Single nutriments market share analysis, 2022
  - 4.4.1.3 Global 2/3 chamber bags market share analysis, 2022
  - 4.4.1.4 Global compounded parenteral nutrition market share analysis, 2022
- 4.4.2 U.S.
  - 4.4.2.1 U.S. RTU/Standard commercial parenteral nutrition
  - 4.4.2.2 U.S. compounded parenteral nutrition market share analysis, 2022
- 4.4.3 China
  - 4.4.3.1 China RTU/Standard commercial parenteral nutrition
  - 4.4.3.2 China compounded parenteral nutrition market share analysis, 2022
- 4.4.4 India
- 4.4.5 Germany
- 4.4.6 France
- 4.4.7 UK
- 4.4.8 Italy
- 4.4.9 Spain
4.5 Competitive analysis of major market players
4.6 Strategy dashboard

Chapter 5 Parenteral Nutrition Market Estimates and Forecast, By Composition, 2018-2032 (USD Million)

5.1 Key trends, by composition
5.2 Amino acids
5.3 Fats
5.4 Carbohydrates
5.5 Trace elements
5.6 Vitamins
5.7 Minerals
5.8 Other compositions

Chapter 6 Parenteral Nutrition Market Estimates and Forecast, By Type, 2018-2032 (USD Million)

6.1 Key trends, by type
6.2 RTU/standard commercial parenteral nutrition
- 6.2.1 Single nutriment
- 6.2.2 RTU 2or 3 chamber bags
6.3 Compounded parenteral nutrition
- 6.3.1 Monobags/mixing bags
- 6.3.2 2 or 3 chamber bags

Chapter 7 Parenteral Nutrition Market Estimates and Forecast, By Consumer, 2018-2032 (USD Million)

7.1 Key trends, by consumer
7.2 Newborn & children
7.3 Adults

Chapter 8 Parenteral Nutrition Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

8.1 Key trends, by end user
8.2 Hospitals
8.3 Clinics
8.4 Homecare settings
8.5 Other End-users

Chapter 9 Parenteral Nutrition Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East & Africa

Chapter 10 Company Profiles

10.1 B. Braun Melsungen AG
10.2 Baxter International, Inc.
10.3 Fresenius Kabi AG
10.4 OTSUKA HOLDINGS CO., LTD
10.5 Amanta Healthcare
10.6 Grifols International S.A.
10.7 ICU Medical
10.8 Aculife Healthcare
10.9 AbbVie, Inc
10.10 Sichuan Kelun Pharmaceutical Co. Ltd.
10.11 Aguettant
10.12 Xian Libang Enterprises
10.13 Anhui Medipharm Co., Ltd.